FDA Panel Will Review Endpoints For Kythera’s Double-Chin Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Kythera and FDA together developed a clinician and a patient assessment of the treatment effect seen with injectable deoxycholic acid as a drug therapy for reducing fatty tissue under the chin or “double chin.”